Spots Global Cancer Trial Database for stage iii endometrial carcinoma
Every month we try and update this database with for stage iii endometrial carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer | NCT00258362 | Endometrial Can... | carboplatin docetaxel radiation thera... | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery | NCT00448643 | Endometrial Can... | Vaginal Brachyt... Cisplatin Whole Abdominal... | 18 Years - 80 Years | University of Miami | |
| Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer | NCT00287885 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... Sarcoma Vaginal Cancer Vulvar Cancer | docetaxel | 18 Years - | Masonic Cancer Center, University of Minnesota | |
| Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer | NCT00245050 | Breast Cancer Drug/Agent Toxi... Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | pyridoxine hydr... Placebo doxorubicin HCL... | - | Case Comprehensive Cancer Center | |
| Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer | NCT00005861 | Endometrial Can... | pegylated lipos... | - | GOG Foundation | |
| Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery | NCT00331760 | Cervical Cancer Endometrial Can... | cisplatin intensity-modul... | 18 Years - | Radiation Therapy Oncology Group | |
| Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer | NCT01119573 | Endometrial Can... | RNA analysis microarray anal... reverse transcr... laboratory biom... | - | National Cancer Institute (NCI) | |
| Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors | NCT00004082 | Endometrial Can... Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin docetaxel gemcitabine hyd... | 18 Years - | National Cancer Institute (NCI) | |
| Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer | NCT00118300 | Cervical Cancer Endometrial Can... Ovarian Cancer Vaginal Cancer | capecitabine brachytherapy radiation thera... | 18 Years - | Case Comprehensive Cancer Center | |
| Ridaforolimus in Treating Patients With Recurrent Metastatic and/or Locally Advanced Endometrial Cancer | NCT00770185 | Endometrial Can... | ridaforolimus gene expression... immunohistochem... laboratory biom... | 18 Years - | Canadian Cancer Trials Group | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer) | NCT00085332 | Endometrial Can... | docetaxel | - | GOG Foundation | |
| Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer | NCT00016341 | Endometrial Can... | filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra... | - | GOG Foundation | |
| Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer | NCT00005842 | Cancer | trastuzumab tipifarnib | 18 Years - | National Cancer Institute (NCI) | |
| Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer | NCT00470067 | Endometrial Can... | carboplatin pegylated lipos... | 18 Years - | Roswell Park Cancer Institute | |
| Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | NCT01155258 | Extensive Stage... Hereditary Para... Male Breast Can... Malignant Parag... Metastatic Gast... Metastatic Pheo... Pancreatic Poly... Recurrent Breas... Recurrent Cervi... Recurrent Endom... Recurrent Gastr... Recurrent Islet... Recurrent Neuro... Recurrent Non-s... Recurrent Ovari... Recurrent Ovari... Recurrent Pheoc... Recurrent Prost... Recurrent Renal... Recurrent Small... Recurrent Uteri... Regional Gastro... Regional Pheoch... Stage III Cervi... Stage III Endom... Stage III Neuro... Stage III Ovari... Stage III Ovari... Stage III Prost... Stage III Renal... Stage III Uteri... Stage IIIA Brea... Stage IIIA Non-... Stage IIIB Brea... Stage IIIB Non-... Stage IIIC Brea... Stage IV Breast... Stage IV Endome... Stage IV Neuroe... Stage IV Non-sm... Stage IV Ovaria... Stage IV Ovaria... Stage IV Prosta... Stage IV Renal ... Stage IV Uterin... Stage IVA Cervi... Stage IVB Cervi... Thyroid Gland M... | temsirolimus vinorelbine dit... | 18 Years - | University of Southern California | |
| Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery | NCT00448643 | Endometrial Can... | Vaginal Brachyt... Cisplatin Whole Abdominal... | 18 Years - 80 Years | University of Miami | |
| Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer | NCT00002493 | Endometrial Can... Psychosocial Ef... | cisplatin doxorubicin hyd... low-LET photon ... | - | GOG Foundation | |
| Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer | NCT00032162 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma | carboplatin pegylated lipos... | 18 Years - | AGO Study Group | |
| Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial Cancer | NCT00016341 | Endometrial Can... | filgrastim cisplatin doxorubicin hyd... megestrol aceta... paclitaxel tamoxifen citra... | - | GOG Foundation | |
| Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer | NCT00003691 | Endometrial Can... | filgrastim cisplatin doxorubicin hyd... paclitaxel | 18 Years - | GOG Foundation | |
| Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer | NCT00245050 | Breast Cancer Drug/Agent Toxi... Endometrial Can... Fallopian Tube ... Ovarian Cancer Peritoneal Cavi... | pyridoxine hydr... Placebo doxorubicin HCL... | - | Case Comprehensive Cancer Center | |
| Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer | NCT00087100 | Endometrial Can... | pemetrexed diso... | - | GOG Foundation | |
| Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | NCT00002949 | Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer | paclitaxel vinorelbine tar... radiation thera... | 18 Years - | University of Chicago | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| EF5 in Finding Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Cervical, Endometrial, or Ovarian Epithelial Cancer | NCT00107445 | Primary Periton... Stage I Endomet... Stage I Ovarian... Stage IA Cervic... Stage IB Cervic... Stage II Endome... Stage II Ovaria... Stage IIA Cervi... Stage IIB Cervi... Stage III Cervi... Stage III Endom... Stage III Ovari... Stage IV Endome... Stage IV Ovaria... Stage IVA Cervi... Stage IVB Cervi... | EF5 | 18 Years - | National Cancer Institute (NCI) | |
| Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | NCT00003624 | Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma | amifostine trih... cisplatin paclitaxel | - | GOG Foundation | |
| Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer | NCT00003624 | Cervical Cancer Endometrial Can... Fallopian Tube ... Neurotoxicity Ovarian Cancer Primary Periton... Sarcoma | amifostine trih... cisplatin paclitaxel | - | GOG Foundation | |
| Doxorubicin, Paclitaxel, and Carboplatin in Treating Patients With Primary Stage III, Stage IV, or Recurrent Endometrial Cancer | NCT00006377 | Endometrial Can... | carboplatin doxorubicin hyd... paclitaxel | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Gene Therapy in Treating Patients With Cancer | NCT00004178 | Cancer | therapeutic aut... | 18 Years - | Roger Williams Medical Center | |
| Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial Cancer | NCT00005861 | Endometrial Can... | pegylated lipos... | - | GOG Foundation | |
| Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer | NCT01150682 | Endometrial Can... | RNA analysis reverse transcr... enzyme-linked i... immunohistochem... laboratory biom... | - | National Cancer Institute (NCI) | |
| Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pelvis | NCT00002949 | Bladder Cancer Cervical Cancer Endometrial Can... Vaginal Cancer | paclitaxel vinorelbine tar... radiation thera... | 18 Years - | University of Chicago | |
| Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer | NCT00002493 | Endometrial Can... Psychosocial Ef... | cisplatin doxorubicin hyd... low-LET photon ... | - | GOG Foundation | |
| Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer | NCT00470067 | Endometrial Can... | carboplatin pegylated lipos... | 18 Years - | Roswell Park Cancer Institute | |
| Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery | NCT00842452 | Cervical Cancer Endometrial Can... Fallopian Tube ... Ovarian Cancer Sarcoma Vaginal Cancer Vulvar Cancer | topotecan hydro... pharmacological... | 18 Years - | Case Comprehensive Cancer Center | |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer | NCT00003704 | Cancer | capecitabine radiation thera... | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery | NCT01939028 | Stage I Endomet... Stage II Endome... Stage III Endom... Stage IV Endome... | lymph node mapp... sentinel lymph ... isosulfan blue indocyanine gre... therapeutic con... lymphadenectomy | - | Case Comprehensive Cancer Center | |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid Tumors | NCT00499291 | Cancer | paclitaxel albu... gene expression... laboratory biom... pharmacological... polymerase chai... | 18 Years - 120 Years | Eastern Cooperative Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
